Date: Wednesday 18 Apr 2012
Apple, Capital One, Comerica, First Solar, Forest Labs, IBM
| Almirall submits new drug application to FDA | 30-Jun-2011 | ShareCast |
| Forest, Maker of Celexa, to Pay More Than $313 M... | 16-Sep-2010 | New York Times |
| Drug Maker Is Accused of Fraud | 26-Feb-2009 | New York Times |
| New River gives Shire control of 'flagship' drug | 21-Feb-2007 | Telegraph |
| Tech Ticker | 15-Dec-2006 | BayArea.com |
| F.D.A. Clears Generic Version of Lexapro | 23-May-2006 | New York Times |
| Stock Futures Point to Rebound | 14-Jul-2006 | Chicago Tribune |
| Forest Asked to Supply Information on Marketing ... | 30-Jun-2004 | New York Times |
| Wall Street slips after data disappoint | 20-Jun-2003 | Intl Herald Tribune |
| Trafficmaster Pulls Away | 08-Jun-2000 | Motley Fool UK |
| Currency | US Dollars |
| Share Price | $ 33.38 |
| Change Today | $ 0.05 |
| % Change | 0.15 % |
| 52 Week High | $40.17 |
| 52 Week Low | $28.55 |
| Volume | 968,281 |
| Shares Issued | 265.53m |
| Market Cap | $8,864m |
| Beta | 0.74 |
| RiskGrade | 84 |
| Time | Volume / Share Price |
| 16:15 | 51,201 @ $33.38 |
| 16:15 | 285 @ $33.38 |
| 16:15 | 100 @ $33.38 |
| 16:14 | 254 @ $33.39 |
| 16:14 | 100 @ $33.39 |
You are here: research